EUROPEAN ASSOCIATION OF HAEMOPHILIA AND ALLIED D..

11th Annual Congress of EAHAD

 

7 – 9 February 2018 Madrid
Close
N. Poster
Poster title
Applicant name
Status
  4-P PREVALENCE OF VITAMIN D DEFICIENCY IN PERSONS WITH SEVERE HAEMOPHILIA IN IRELAND Deirdre Gorman Received Received
  5-P CHRONIC PAIN IN HAEMOPHILIA:EVIDENCE BASED PSYCHOLOGICAL APPROACHES TO BETTER MANAGEMENT Cleary Janet Received Received
  6-P PERSISTENT EFFECTIVENESS OF PROPHYLAXIS WITH RECOMBINANT FACTOR VIII CONCENTRATE IN PATIENTS WITH HEMOPHILIA A IN A REAL WORLD SETTING OVER 4 YEARS (INTERNATIONAL AHEAD STUDY) Dana Scott Received Received
  14-P OUTPATIENT PHYSIOTERAPIC MANAGEMENT AT BIANCHI BONOMI HEMOFILIA CENTER: 20-YEAR EXPERIENCE Boccalandro Elena Received Received
  21-P SAFETY AND EFFECTIVENESS OF FASCIAL THERAPY IN ADULT PATIENTS WITH HEMOPHILIC ARTHROPATHY OF ANKLE. A COHORT STUDY. Rubén Cuesta-Barriuso Received Received
  22-P SAFETY AND EFFICACY OF MANUAL AND EDUCATIONAL THERAPY IN THE TREATMENT OF HEMOPHILIC ARTHROPATHY OF THE ELBOW. A RANDOMIZED CLINICAL TRIAL. Rubén Cuesta-Barriuso Received Received
  30-P HEALTH RELATED QUALITY OF LIFE, DEVELOPMENTAL MILESTONES AND SELF-ESTEEM IN YOUNG ADULTS WITH CONGENITAL BLEEDING DISORDERS Lotte Haverman Received Received
  41-P BLEEDING RISK IN HEMOPHILIA PATIENT UNDERGOING ANTITHROMBOTIC THERAPY, RESULTS OF THE EHREA MULTICENTRIC STUDY ALEXANDRE DESJONQUERES Received Received
  43-P COMPARISON OF THREE ASSAYS FOR MEASURING FACTOR IX Amy DERICQUEBOURG Received Received
  49-P CLINICAL REVIEW OF PIVOTAL TRIALS ON OCTOCOG-ALFA (KOVALTRY) AND OTHER RECOMBINANT FVIII IN PATIENTS WITH HAEMOPHILIA A Lucia Sara DAngiolella Received Received
  51-P BENEFITS OF SWITCH TO FVIII-FC: EXPERIENCE OF PROPHYLAXIS IN EIGHT PATIENTS annarita tagliaferri Received Received
  53-P THE FIX:C ASSESSMENT OF EXTENDED HALF-LIFE RECOMBINANT FACTOR IX PRODUCTS IN CLINICAL PRACTICE Annette Bowyer Received Received
  55-P Comparison of Standard Half-Life to Extended Half-Life FIX Products: Real-World Analysis of Recent Factor IUs Dispensed and Expenditures in On-Demand Hemophilia B Patients Ashley Daset Received Received
  60-P IMPACT OF PRE-EXISTING IMMUNITY TO AAV5 ON PHARMACODYNAMICS OF BMN 270, AN AAV5-BASED GENE THERAPY FOR THE TREATMENT OF HEMOPHILIA A Simin Batroff Received Received
  61-P INTERIM ANALYSIS OF IMMUNOGENICITY TO THE VECTOR CAPSID AND TRANSGENE-EXPRESSED HUMAN FVIII IN A PHASE-1/2 CLINICAL STUDY OF BMN-270, AN AAV5 MEDIATED GENE THERAPY FOR HEMOPHILIA A Simin Batroff Received Received
  68-P PATIENTS WITH BLEEDING OF UNKNOWN CAUSE AND JOINT HYPERMOBILITY: CLINICAL ASSESSMENT AND GENETIC SCREENING marta Martorell Received Received
  71-P PREVALENCE OF OVERWEIGHT IN YOUNG PATIENTS WITH SEVERE HAEMOPHILIA AND ITS ECONOMIC BURDEN IN GERMANY Christoph Bidlingmaier Received Received
  75-P THE WFH WORLD BLEEDING DISORDERS REGISTRY Mark Brooker Received Received
  83-P PATIENT PERSPECTIVES ON CURRENT AND FUTURE HAEMOPHILIA TREATMENT Erna van Balen Received Received
  85-P DRUG CONSUMPTION AND COST ESTIMATES FOR DIFFERENT RECOMBINANT FACTOR VIII PRODUCTS APPROVED FOR REPLACEMENT TREATMENT IN PATIENTS WITH HEMOPHILIA A IN ITALY Alessandro ROGGERI Received Received
  97-P PERIPROSTHETIC BONE MINERAL DENSITY AFTER ANKLE PROTHESIS. PRELIMINARY OBSERVATIONS FROM TWO CLINICAL CASES. Giulia Rebagliati Received Received
  114-P ASSOCIATED IMPACT OF ACTIVITY IMPAIRMENT ON CLINICAL AND PATIENT-CENTRIC OUTCOMES IN SEVERE HAEMOPHILIA Aji NAIR Received Received
  115-P ASSOCIATED IMPACT OF WORK IMPAIRMENT ON CLINICAL AND PATIENT-CENTRIC OUTCOMES IN SEVERE HAEMOPHILIA Aji NAIR Received Received
  117-P RECOMBINANT VON WILLEBRAND FACTOR (RVWF) ADMINISTRATION: DOSING CONSIDERATIONS AND RAPID STABILIZATION OF ENDOGENOUS PLASMA FVIII LEVELS IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE Dana Scott Received Received
  118-P DOES ADAMTS13 INFLUENCE THE BLEEDING PHENOTYPE IN PATIENTS WITH VON WILLEBRAND DISEASE? Johan Boender Received Received
  121-P SIMULTANEOUS THROMBIN AND PLASMIN GENERATION IN PATIENTS WITH PLASMINOGEN OR PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 DEFICIENCY Joline Saes Received Received
  122-P WHOLE EXOME SEQUENCING IN PATIENTS WITH A BLEEDING TENDENCY Joline Saes Received Received
  125-P ONLINE COURSE OF PHARMACOKINETIC MONITORING IN HEMOPHILIA WITH APPLICATION IN THE CLINICAL PRACTICE Juan Eduardo Megías Vericat Received Received
  126-P INDIVIDUALIZATION OF PROPHYLAXIS WITH RECOMBINANT FACTOR VIII IN SEVERE OR MODERATE HEMOPHILIA A Juan Eduardo Megías Vericat Received Received
  128-P PHYSICAL ACTIVITY AND HEALTH OUTCOMES IN SEVERE HEMOPHILIA A PATIENTS ON PROPHYLAXIS WITH CONVENTIONAL RFVIII VS. RFVIIIFC Nanxin Li Received Received
  129-P CASE REPORT: A SUCCESSFUL PREGNANCY IN HAEMOPHILLIA A Jun Yong Received Received
  145-P INSIGHT INTO THE REAL-LIFE OF PERSONS WITH HAEMOPHILIA (PWH).IMPACT OF RECENTLY INTRODUCED PROPHYLACTIC REPLACEMENT Margit Serban Received Received
  150-P DOES BLOOD GROUP 0 INFLUENCE INHIBITOR DEVELOPMENT? DATA FROM THE PEDNET REGISTRY Marloes de Kovel Received Received
  152-P F9 GENOTYPE AND PK HEMOPHILIA B ITALIAN STUDY (GEPKHIS Massimo Morfini Received Received
  154-P HEMOPHILIACS MANAGEMENT IN AN EMERGENCY DEPARTMENT:A 7-YEARS SURVEY TO IDENTIFY AREAS FOR SAFETY AND QUALITY IMPROVEMENT. Michael HOANG Received Received
  156-P JOINT OUTCOME IN FOUR YEARS FOLLOW-UP IN CHILDREN WITH HEMOPHILIA TREATED WITH EARLY PROPHYLAXIS Minna Koskenvuo Received Received
  158-P PLATELETS DISORDER IN A CASE OF CHRONIC LYMPHOCYTIC LEUKEMIA (LLC) Corrado Lodigiani Received Received
  163-P AUDIT OF BLEEDING COMPLICATIONS FOLLOWING INVASIVE PROCEDURES AND MINOR SURGERIES IN PATIENTS WITH BLEEDING DISORDERS: CONSIDERING A RATIONALE FOR SAFE SAME DAY DISCHARGE Naoimh Herlihy Received Received
  165-P EFFICACY ON PAIN OF A SINGLE INJECTION OF HYALURONIC ACID IN HAEMOPHILIC ARTHROPATHY OF THE ANKLE: A PROSPECTIVE STUDY Castet Sabine Received Received
  177-P ANNUAL BLEEDING RATE AND BLEEDING-RELATED FACTOR-REPLACEMENTTHERAPYCOSTS IN HEMOPHILIA A AND B IN REAL-LIFE CLINICAL PRACTICE: A 4-YEAR FOLLOW-UP STUDY IN FINLAND Riitta Lassila Received Received
  179-P REAL-WORLD BLEEDING FREQUENCY IN INHIBITOR PATIENTS ON PROPHYLAXIS WITH APCC: DATA READ-OUT OF THE FEIBA GLOBAL OUTCOMES STUDY (FEIBA GO) Dana Scott Received Received
  180-P TOLERABILITY/SAFETY OF FEIBA RECONSTITUTED IN REGULAR OR 50 REDUCED VOLUME AND FASTER INFUSION RATES: RATIONALE AND STUDY DESIGN IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS Dana Scott Received Received
  181-P REAL WORLD USE OF B-DOMAINDELETED, PORCINE-SEQUENCE FACTOR VIII (RPFVIII) IN PATIENTS WITH ACQUIRED HAEMOPHILIA A (AHA): POST-MARKETING SAFETY (PMS) STUDIES IN EUROPEAN UNION (EU) AND IN THE UNITED STATES (US) Dana Scott Received Received
  184-P COMBINED PROTHROMBIN AND FACTOR XI DEFICIENCY IN A LEBANESE FAMILY Roula Farah Received Received
  186-P MEASUREMENT OF JOINT STATUS IN PATIENTS WITH HAEMOPHILIA: A SYSTEMATIC REVIEW OF THE MEASUREMENT PROPERTIES OF HAEMOPHILIA-SPECIFIC JOINT EXAMINATION SCORES Samantha Gouw Received Received
  191-P RECOMBINANT FVIII PRODUCT TYPE AND THE RISK OF INHIBITOR DEVELOPMENT IN PREVIOUSLY TREATED PATIENTS WITH HEMOPHILIA A: A SYSTEMATIC REVIEW AND META-ANALYSIS Shermarke Hassan Received Received
  196-P THERAPEUTIC LEVELS OF HUMAN FVIII IN MICE AND PRIMATES AND NORMALIZATION OF BLEEDING IN HEMOPHILIC MICE FOLLOWING GENE THERAPY WITH BMN 270 Sylvia Fong Received Received
  197-P MANAGMENT OF DELIVERIES IN CARRIERS FOR HEMOPHILA A AND LOW FVIII LEVELS WITH RECOMBINANT FVIIIFC FUSION PROTEIN Susan Halimeh Received Received
  202-P SURGICAL INTERVENTIONS IN PATIENTS WITH HEMOPHILIA: OUTCOME OF TREATMENT AT A SINGLE CENTER IN LOW-RESOURCE SETTINGS Tuan NGUYEN Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:30, Fri 8:30-15:00
07:22
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image
 

EUROPEAN ASSOCIATION OF HAEMOPHILIA AND ALLIED D..

11th Annual Congress of EAHAD

 

7 – 9 February 2018 Madrid
HELP LINE
Manage Orders
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 07/02/2018 TO 07/02/2018
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                   DOI: 10.3252/pso.eu.EAHAD2018.2018 
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 04/02/2018
Upload Poster
Upload Oral Presentation of Video
Check your Poster
Upload
Poster
Upload Oral
Presentation or Video
Check
your Poster




PosterSessionOnline
Logo Draft
 
Logo Cert